The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $114.44

Today's change+6.09 +5.62%
Updated July 27 4:01 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $114.44

Today's change+6.09 +5.62%
Updated July 27 4:01 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp Hits New 52-week High

Edwards Lifesciences Corp closed up sharply Wednesday, rallying (U.S.)$6.09 or 5.62% to (U.S.)$114.44 and setting a new 52-week high. Over the last five days, shares have gained 7.24% and are currently 2.57% off of the 52-week high. Shares have outperformed the S&P 500 by 45.08% during the last year.

Key company metrics

  • Open(U.S.) $116.15
  • Previous close(U.S.) $108.35
  • High(U.S.) $117.46
  • Low(U.S.) $114.01
  • Bid / Ask-- / --
  • YTD % change+44.90%
  • Volume5,105,030
  • Average volume (10-day)1,643,229
  • Average volume (1-month)1,712,618
  • Average volume (3-month)1,780,360
  • 52-week range(U.S.) $62.53 to (U.S.) $117.46
  • Beta0.51
  • Trailing P/E48.76×
  • P/E 1 year forward39.20×
  • Forward PEG2.33×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.35
Updated July 27 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue697671616617
Total other revenue--------
Total revenue697671616617
Gross profit517495469458
Total cost of revenue180176147159
Total operating expense514504465475
Selling / general / administrative213222212214
Research & development1029810198
Depreciation / amortization--------
Interest expense (income), net operating--544
Unusual expense (income)12321
Other operating expenses, total5100
Operating income183167151142
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax183167151142
Income after tax143141118113
Income tax, total40263330
Net income143141118113
Total adjustments to net income--------
Net income before extra. items143141118113
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items143141118113
Inc. avail. to common incl. extra. items143141118113
Diluted net income143141118113
Dilution adjustment0100
Diluted weighted average shares218221220220
Diluted EPS excluding extraordinary itemsvalue per share0.660.640.540.51
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.700.650.550.52